Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.

Saved in:
Bibliographic Details
Title: Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.
Authors: Giani C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Denu RA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Ljevar S; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gronchi A; Department of Sarcoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Napolitano A; Department of Medical Oncology, The Royal Marsden NHS, London, UK., Rosenbaum E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Salawu A; Division of Medical Oncology and Hematology, Mount Sinai Hospital and Princess Margaret Cancer Centre, Toronto, Canada., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homibhabha National University, Mumbai, India., Connolly EA; Central Clinical School, Faculty of Medicine and Health Science, The University of Sydney, Sydney, Australia., Lee ATJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Trent JC; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA., Koseła-Paterczyk H; Department of Medical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Chia-Chen Li Z; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Ogura K; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Palmerini E; Department of Medical Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Baldi GG; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Brunello A; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy., Campos F; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil., Cicala CM; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Maki RG; Department of Medical Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA., Wagner AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Andelkovic V; Department of Medical Oncology, Princess Alexandra Hospital (PAH), Woolloongabba, Australia., Loong HH; Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Wong DD; Department of Anatomical Pathology, PathWest, Sir Charles Gairdner Hospital, Perth, Australia., Jones RL; Department of Medical Oncology, The Royal Marsden NHS, London, UK., Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Taverna SM; Technology Transfer Office, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lazar AJ; Department of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Demicco EG; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Hong A; Central Clinical School, Faculty of Medicine and Health Science, The University of Sydney, Sydney, Australia., Bovee JVMG; Department of Pathology, Leiden University Medical Center (LUMC), Leiden, The Netherlands., Dei Tos AP; Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy., Fletcher CDM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA., Baumhoer D; Department of Pathology, University Hospital Basel, Basel, Switzerland., Sbaraglia M; Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy., Schaefer IM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA., Miceli R; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Stacchiotti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.
Source: ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103689. Date of Electronic Publication: 2024 Sep 11.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39265219
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Giani+C%22">Giani C</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Denu+RA%22">Denu RA</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Ljevar+S%22">Ljevar S</searchLink>; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Gronchi+A%22">Gronchi A</searchLink>; Department of Sarcoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Napolitano+A%22">Napolitano A</searchLink>; Department of Medical Oncology, The Royal Marsden NHS, London, UK.<br /><searchLink fieldCode="AU" term="%22Rosenbaum+E%22">Rosenbaum E</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Salawu+A%22">Salawu A</searchLink>; Division of Medical Oncology and Hematology, Mount Sinai Hospital and Princess Margaret Cancer Centre, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Bajpai+J%22">Bajpai J</searchLink>; Department of Medical Oncology, Tata Memorial Centre, Homibhabha National University, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Connolly+EA%22">Connolly EA</searchLink>; Central Clinical School, Faculty of Medicine and Health Science, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+ATJ%22">Lee ATJ</searchLink>; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Trent+JC%22">Trent JC</searchLink>; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.<br /><searchLink fieldCode="AU" term="%22Koseła-Paterczyk+H%22">Koseła-Paterczyk H</searchLink>; Department of Medical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Chia-Chen+Li+Z%22">Chia-Chen Li Z</searchLink>; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ogura+K%22">Ogura K</searchLink>; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Palmerini+E%22">Palmerini E</searchLink>; Department of Medical Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Baldi+GG%22">Baldi GG</searchLink>; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.<br /><searchLink fieldCode="AU" term="%22Brunello+A%22">Brunello A</searchLink>; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Campos+F%22">Campos F</searchLink>; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Cicala+CM%22">Cicala CM</searchLink>; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Maki+RG%22">Maki RG</searchLink>; Department of Medical Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.<br /><searchLink fieldCode="AU" term="%22Wagner+AJ%22">Wagner AJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Andelkovic+V%22">Andelkovic V</searchLink>; Department of Medical Oncology, Princess Alexandra Hospital (PAH), Woolloongabba, Australia.<br /><searchLink fieldCode="AU" term="%22Loong+HH%22">Loong HH</searchLink>; Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Wong+DD%22">Wong DD</searchLink>; Department of Anatomical Pathology, PathWest, Sir Charles Gairdner Hospital, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Jones+RL%22">Jones RL</searchLink>; Department of Medical Oncology, The Royal Marsden NHS, London, UK.<br /><searchLink fieldCode="AU" term="%22Tap+WD%22">Tap WD</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Taverna+SM%22">Taverna SM</searchLink>; Technology Transfer Office, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Department of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Demicco+EG%22">Demicco EG</searchLink>; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Hong+A%22">Hong A</searchLink>; Central Clinical School, Faculty of Medicine and Health Science, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Bovee+JVMG%22">Bovee JVMG</searchLink>; Department of Pathology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dei+Tos+AP%22">Dei Tos AP</searchLink>; Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Fletcher+CDM%22">Fletcher CDM</searchLink>; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Baumhoer+D%22">Baumhoer D</searchLink>; Department of Pathology, University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sbaraglia+M%22">Sbaraglia M</searchLink>; Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Schaefer+IM%22">Schaefer IM</searchLink>; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Miceli+R%22">Miceli R</searchLink>; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Stacchiotti+S%22">Stacchiotti S</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103689. <i>Date of Electronic Publication: </i>2024 Sep 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39265219
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2024.103689
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 103689
    Titles:
      – TitleFull: Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Giani C
      – PersonEntity:
          Name:
            NameFull: Denu RA
      – PersonEntity:
          Name:
            NameFull: Ljevar S
      – PersonEntity:
          Name:
            NameFull: Gronchi A
      – PersonEntity:
          Name:
            NameFull: Napolitano A
      – PersonEntity:
          Name:
            NameFull: Rosenbaum E
      – PersonEntity:
          Name:
            NameFull: Salawu A
      – PersonEntity:
          Name:
            NameFull: Bajpai J
      – PersonEntity:
          Name:
            NameFull: Connolly EA
      – PersonEntity:
          Name:
            NameFull: Lee ATJ
      – PersonEntity:
          Name:
            NameFull: Trent JC
      – PersonEntity:
          Name:
            NameFull: Koseła-Paterczyk H
      – PersonEntity:
          Name:
            NameFull: Chia-Chen Li Z
      – PersonEntity:
          Name:
            NameFull: Ogura K
      – PersonEntity:
          Name:
            NameFull: Palmerini E
      – PersonEntity:
          Name:
            NameFull: Baldi GG
      – PersonEntity:
          Name:
            NameFull: Brunello A
      – PersonEntity:
          Name:
            NameFull: Campos F
      – PersonEntity:
          Name:
            NameFull: Cicala CM
      – PersonEntity:
          Name:
            NameFull: Maki RG
      – PersonEntity:
          Name:
            NameFull: Wagner AJ
      – PersonEntity:
          Name:
            NameFull: Andelkovic V
      – PersonEntity:
          Name:
            NameFull: Loong HH
      – PersonEntity:
          Name:
            NameFull: Wong DD
      – PersonEntity:
          Name:
            NameFull: Jones RL
      – PersonEntity:
          Name:
            NameFull: Tap WD
      – PersonEntity:
          Name:
            NameFull: Taverna SM
      – PersonEntity:
          Name:
            NameFull: Lazar AJ
      – PersonEntity:
          Name:
            NameFull: Demicco EG
      – PersonEntity:
          Name:
            NameFull: Hong A
      – PersonEntity:
          Name:
            NameFull: Bovee JVMG
      – PersonEntity:
          Name:
            NameFull: Dei Tos AP
      – PersonEntity:
          Name:
            NameFull: Fletcher CDM
      – PersonEntity:
          Name:
            NameFull: Baumhoer D
      – PersonEntity:
          Name:
            NameFull: Sbaraglia M
      – PersonEntity:
          Name:
            NameFull: Schaefer IM
      – PersonEntity:
          Name:
            NameFull: Miceli R
      – PersonEntity:
          Name:
            NameFull: Stacchiotti S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1